Jupiter Endovascular raised $21M in new financing led by Sonder Capital to fund a pivotal trial for Pulmonary Embolism.
Amount Raised
$21 Million
Round Type
Funding Round
Menlo ParkBiotechnologyHealth Caremedical devicesInvestors
Description
Jupiter Endovascular has exited stealth mode with a $21 million round of financing. The funding will support the company's upcoming pivotal trial for Pulmonary Embolism and further development of its Endoportal ControlTM technology.
Quick answer
Jupiter Endovascular raised $21 Million in a Funding Round round, dated August 15, 2024. Investors: Sonder Capital. Jupiter Endovascular is based in Menlo Park, California, United States.
- How much did Jupiter Endovascular raise?
- Jupiter Endovascular raised $21 Million in a Funding Round round on August 15, 2024.
- Who invested in Jupiter Endovascular?
- Sonder Capital is named as investors in this round.
- What does Jupiter Endovascular do?
- Jupiter Endovascular is a medical technology startup developing the “endoportal procedure,” a new class of endovascular interventions using Endoportal Control to bring the precision and control of direct surgical access..
- Where is Jupiter Endovascular based and how big is it?
- Jupiter Endovascular is based in Menlo Park, California, United States. Fundz records about 45 employees.
- Who are the decision-makers at Jupiter Endovascular?
- Fundz holds 2 contacts at Jupiter Endovascular. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Who else raised in medical devices and Biotechnology around the same time
Companies in the same sectors as Jupiter Endovascular that raised within 45 days of this round, from Fundz verified event records.
- SpectraWAVE raised $50M (Series B) on September 11, 2024.
- SpectraWAVE raised $49M on September 4, 2024.
- BrainsWay raised $20M on September 29, 2024.
- 22nd Century raised $1.2M (Seed) on September 27, 2024.
- Mendaera raised $73M (Series B) on September 26, 2024.
- CERo Therapeutics Holdings raised $1.3M (Seed) on September 26, 2024.
Who to call at Jupiter Endovascular, and when
A new round usually means Jupiter Endovascular is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Jupiter Endovascular raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Jupiter Endovascular, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Jupiter Endovascular. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Jupiter Endovascular raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Jupiter Endovascular raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.